A large number of the human microRNAs target lentiviruses, retroviruses, and endogenous retroviruses

Biochemical and Biophysical Research Communications

Volumn 369, Issue 2, 2008, Pages 357-362

  Hakim, Shazia T ^b   Alsayari, Mohammad ^a   McLean, David C ^a   Saleem, Sajid ^a   Addanki, Krishna C ^a   Aggarwal, Mayank ^a   Mahalingam, Kuha ^a   Bagasra, Omar ^a  

^a CLAFLIN UNIVERSITY   (United States)

^b JINNAH UNIVERSITY FOR WOMEN   (Pakistan)

Author keywords

Endogenous retroviruses; Latency; Lentivirus; MicroRNA; Retrovirus

Indexed keywords

MICRORNA;

ARTICLE; GENE CONTROL; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS LATENCY;

BASE SEQUENCE; DNA, VIRAL; ENDOGENOUS RETROVIRUSES; GENE TARGETING; HUMANS; LENTIVIRUS; MICRORNAS; MOLECULAR SEQUENCE DATA; RETROVIRIDAE; SEQUENCE ANALYSIS, RNA;

EUKARYOTA; HOMO SAPIENS; HUMAN ENDOGENOUS RETROVIRUSES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; LENTIVIRUS; PRIMATES;

EID: 40849130119     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.025     Document Type: Article

References (37)

1. Matzke M.A., Mette M.F., and Matzke A.J. Transgene silencing by the host genome defense: implications for the evolution of epigenetic control mechanisms in plants and vertebrates. Plant Mol. Biol. 43 2-3 (2000) 401-415
2. Kidwell M.G., and Lisch D.R. Perspective: transposable elements, parasitic DNA, and genome evolution. Evolution Int. J. Org. Evolution 55 1 (2001) 1-24
3. Bagasra O., and Prilliman K.P. RNA Interference. J. Mol. Histol. 35 (2004) 545-553
4. Bagasra O. A unified concept of HIV latency. Expert Opin. Biol. Ther. 6 11 (2006) 1135-1149
5. Mattick J.S., and Makunin I.V. Non-coding RNA. Hum. Mol. Genet. Spec. No. 1 (2006) R17-R29
6. Bagasra O., Stir A.E., Pirisi-Creek L., Creek K.E., Bagasra A., and Lee J.S. Role of miRNAs in regulation of lentiviral latency and persistence. Appl. Immunochem. Mol. Morphol. 14 (2006) 166-190
7. Taganov K.D., Boldin M.P., and Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2 (2007) 133-137
8. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 2 (2004) 281-297
9. Watanabe Y., Kishi A., Yachie N., Kanai A., and Tomita M. Computational analysis of microRNA-mediated antiviral defense in humans. FEBS Lett. 581 24 (2007) 4603-4610
10. Sijen T., and Plasterk R.H. Transposon silencing in the Caenorhabditis elegans germ line by natural RNAi. Nature 426 6964 (2003) 310-314
11. Piriyapongsa J., and Jordan I.K. A family of human microRNA genes from miniature inverted-repeat transposable elements. PLoS ONE 2 (2007) e203
12. Apetrei C., Robertson D.L., and Marx P.A. The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates NHP in Africa. Front. Biosci. 9 (2004) 225-254
13. Blond J.L., Cheynet V., and Mallet F. Biological significance of human endogenous retroviruses. Virologie 5 (2001) 91-111
14. Bock M., and Stoye J.P. Endogenous retroviruses and the human germline. Curr. Opin. Genet. Dev. 10 6 (2000) 651-655
15. Blond J.L., Lavillette D., Cheynet V., Bouton O., Oriol G., Chapel-Fernandes S., Mandrand B., Mallet F., and Cosset F.L. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J. Virol. 74 (2000) 3321-3329
16. Mills R.E., Bennett E.A., Iskow R.C., and Devine S.E. Which transposable elements are active in the human genome?. Trends Genet. 23 4 (2007) 183-191
17. Büscher K., Hahn S., Hofmann M., Trefzer U., Ozel M., Sterry W., Löwer J., Löwer R., Kurth R., and Denner J. Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res. 16 3 (2006) 223-234
18. Bagasra O. HIV and Molecular Immunity: Prospect for AIDS Vaccine (1999), Eaton publishing, Natic, MA
19. Delelis O., Lehmann-Che J., and Saïb A. Foamy viruses-a world apart. Curr. Opin. Microbiol. 7 4 (2004) 400-406
20. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., and Enright A.J. miRbase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34 Database issue (2006) D140-D144
21. Belshaw R., Dawson A.L., Woolven-Allen J., Redding J., Burt A., and Tristem M. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K (HML2): implications for present-day activity. J. Virol. 79 19 (2005) 12507-12514
22. Rote N.S., Chakrabarti S., and Stetzer B.P. The role of human endogenous retroviruses in trophoblast differentiation and placental development. Placenta 25 8-9 (2004) 673-683
23. Bonnaud B., Bouton O., Oriol G., Cheynet V., Duret L., and Mallet F. Evidence of selection on the domesticated ERVWE1 env retroviral element involved in placentation. Mol. Biol. Evol. 21 (2004) 1895-1901
24. Feuer G., and Green P.L. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24 39 (2005) 5996-6004
25. Verdonck K., González E., Van Dooren S., Vandamme A.M., Vanham G., and Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect. Dis. 7 4 (2007) 266-281
26. Kloosterman W.P., and Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 11 4 (2006) 441-450
27. Lecellier C.H., Dunoyer P., Arar K., Lehmann-Che J., Eyquem S., Himber C., Saïb A., and Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science 308 5721 (2005) 557-560
28. Wolfe N.D., Heneine W., Carr J.K., Garcia A.D., Shanmugam V., Tamoufe U., Torimiro J.N., Prosser A.T., Lebreton M., Mpoudi-Ngole E., et al. Emergence of unique primateT-lymphotropic viruses among central African bushmeat hunters. Proc. Natl. Acad. Sci. USA 102 22 (2005) 7994-7999
29. Araujo A., and Hall W.W. Human T-lymphotropic virus type II and neurological disease. Ann. Neurol. 56 1 (2004) 10-19
30. Cullen B.R. Viruses and microRNAs. Nat. Genet. 38 Suppl (2006) S25-S30
31. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., Sharon E., Spector Y., and Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37 7 (2005) 766-770
32. Berezikov E., Guryev M., van de Belt J., Wienholds E., PlasterkM R.H., and Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120 1 (2005) 21-24
33. Bagasra O. RNAi as an anti-viral therapy. Expert Opin. Biol. Ther. 5 11 (2005) 1463-1467
34. Peeters M., Courgnaudm V., Abelam B., Auzel P., Pourrut X., Bibollet-Ruche F., Loul S., Liegeois F., Butel C., Koulagna D., Mpoudi-Ngole E., Shaw G.M., Hahn B.H., and Delaporte E. Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg. Infect. Dis. 8 5 (2002) 451-457
35. Sotir M., Switzer W., Schable C., Schmitt J., Vitek C., and Khabbaz R.F. Risk of occupational exposure to potentially infectious nonhuman primate materials and to simian immunodeficiency virus. J. Med. Primatol. 26 5 (1997) 233-240
36. Besnier C., Takeuchi Y., and Towers G. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. USA 99 (2002) 11920-11925
37. Cowan S., Hatziioannou T., Cunningham T., Muesing M.A., Gottlinger H.G., and Bieniasz P.D. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc. Natl. Acad. Sci. USA 99 (2002) 11914-11919